Hernando Yesid Estupiñán Velásquez

Has grant

Karolinska University Hospital

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Scholarship Program No. 756

Open Date:

Close Date:

Articles (9)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Rula Zain

Karolinska University Hospital

SWEDEN

View details

Olle Kämpe

Karolinska Institutet

SWEDEN

View details

Thibault Bouderlique

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hernando Yesid Estupiñán Velásquez

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (9)

Three Adult Cases of STAT1 Gain-of-Function with Chronic Mucocutaneous Candidiasis Treated with JAK Inhibitors.

Morphologic characterization of the posterior inferior cerebellar artery. A direct anatomic study.

Identification to cardiac conduction cells in humans and pigs according to their zonal distribution, using histological, immunohistochemical and morphometric study.

BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib

Ibrutinib Has Time-dependent On- and Off-target Effects on Plasma Biomarkers and Immune Cells in Chronic Lymphocytic Leukemia.

Comparative Analysis of BTK Inhibitors and Mechanisms Underlying Adverse Effects.

Morphometric analysis of cardiac conduction fibers in horses and dogs, a comparative histological and immunohistochemical study with findings in human hearts.

Morphologic characterization of the anterior inferior cerebellar artery: a direct anatomic study.

Novel mouse model resistant to irreversible BTK inhibitors: a tool identifying new therapeutic targets and side effects

Collaborators (3)

Rula Zain

Olle Kämpe

Thibault Bouderlique

Make your next move.